Absci Corporation (ABSI) vs Zenas BioPharma, Inc. (ZBIO)
Absci Corporation and Zenas BioPharma, Inc. are both Biotechnology companies. Absci Corporation and Zenas BioPharma, Inc. are of similar size ($1.8B and $1.8B). Zenas BioPharma, Inc. has the higher net margin (0.00% vs −7,756.4%) and the higher return on invested capital (0.00% vs −174.7%). Across the 13 metrics below, Absci Corporation leads on 7 and Zenas BioPharma, Inc. on 6.
Valuation
Profitability
| Metric | ABSI | ZBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (8,084.50%) | 0.00% | 0.00% |
| Net margin | (7,756.37%) | 0.00% | 0.00% |
| Free cash flow margin | (6,969.83%) | 0.00% | 0.00% |
| Return on equity | (57.72%) | (199.04%) | (57.72%) |
| Return on assets | (50.57%) | (97.39%) | (49.22%) |
| Return on invested capital | (174.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack